Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BENIPRO: N0728 in Men With Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia
NCT06546735Phase 3Not yet recruiting
- Sponsor
- Eurofarma
- Start
- Nov 2026
- Primary completion
- Apr 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of N0728 in lower urinary tract symptoms (LUTS), sponsored by Eurofarma. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
N0728
03
Conditions
lower urinary tract symptoms (LUTS)
Beyond the preview
Go deeper on NCT06546735.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06546735.